New Diarrhea Vaccine Shows Promise in Human Trials

Scientists at the University of Guelph have successfully tested the world's first vaccine against Campylobacter jejuni, a bacterial infection that causes millions of cases of severe diarrhea worldwide each year.

The Phase 1 trial showed the vaccine is safe and triggers strong immune responses at even low doses.